KM Pharm exports 1.2 million hand sanitizers to the US

[Asia Economy Reporter Yoo Hyun-seok] Lifestyle beauty specialist KM Pharmaceutical announced on the 28th that it will export 1.2 million hand sanitizers, officially approved for sale by the US FDA on the 8th, to the United States through the cosmetics distribution company CBox Korea.

The products being exported this time are 1 million units of the 60ml 'Jit' hand sanitizer and 200,000 units of the 500ml 'New Ego Round' disinfectant, all of which are quasi-drugs officially approved by the Ministry of Food and Drug Safety (MFDS). The ethanol content of each product is 62% and 70%, respectively.

The hand sanitizer developed by KM Pharmaceutical is a product that allows easy sterilization and disinfection without a drop of water and does not leave stickiness when used. It provides 99.9% sterilization and disinfection effects by removing bacteria without irritating the skin on the back of the hand.

A KM Pharmaceutical official stated, “As COVID-19 has recently spread worldwide, inquiries to supply hand sanitizers to our company have been pouring in, and if continuous exports proceed through the cosmetics specialist distributor CBox Korea, sales in 2020 are expected to increase significantly.”

Established in 2001, KM Pharmaceutical Co., Ltd. completed the construction of a dedicated cosmetics production line on a site of 7,206㎡ near its headquarters in Pyeongtaek, Gyeonggi Province, with a building area of 4,840㎡, and started mass production in March.

This content was produced with the assistance of AI translation services.